NASDAQ:ORGS

Orgenesis Stock Insider Trading

Healthcare > Biotechnology

Buy ORGS

*Your capital is at risk

$0.590

+0.0950 (+19.19%)

At Close: Jun 03, 2026

Orgenesis Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 98.49. In total, the insiders bought 4.47M and sold 60K ORGS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	98.49
● Buy	4.47M shares
● Sell	60K shares
94% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Apr 06, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 98.49. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (94% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 28, 2024 Buy	Common Stock J-Other	Pelavin Adam	Director	0 Value: $0
Oct 28, 2024 Buy	Common Stock J-Other	Bhalaji Jagannathan	Director	0 Value: $0
Oct 28, 2024 Buy	Common Stock J-Other	Nagaraj Santhosh	Director	0 Value: $0
Aug 21, 2024 Buy	Warrant (right to buy) A-Award	Safier Jacob 10 Percent Owner	10% Owner	970 873 Value: $1,000.0K
Aug 21, 2024 Buy	Warrant (right to buy) A-Award	Safier Jacob 10 Percent Owner	10% Owner	970 873 Value: $1,000.0K
Jul 23, 2024 Buy	Stock Option (Right to Buy) A-Award	Caplan Vered CEO & Chairman Of The Board	CEO / President	85 000 Value: $54.4K
Jul 23, 2024 Buy	Stock Option (Right to Buy) A-Award	Nanda Ashish Director	Director	189 320 Value: $121.2K
Jul 23, 2024 Buy	Stock Option (Right to Buy) A-Award	Nanda Ashish Director	Director	189 320 Value: $195.0K
Jul 23, 2024 Buy	Stock Option (Right to Buy) A-Award	Nanda Ashish Director	Director	189 320 Value: $195.0K
Jul 23, 2024 Buy	Stock Option (Right to Buy) A-Award	Nanda Ashish Director	Director	189 320 Value: $121.2K
Jul 23, 2024 Buy	Stock Option (Right to Buy) A-Award	Caplan Vered CEO & Chairman Of The Board	CEO / President	85 000 Value: $54.4K
Jul 08, 2024 Buy	Stock Option (Right to Buy) A-Award	Vider Itzhak Director	Director	6 250 Value: $4K
Jul 08, 2024 Buy	Common Stock J-Other	Vider Itzhak	Director	0 Value: $0
Jul 08, 2024 Buy	Common Stock J-Other	Vider Itzhak	Director	0 Value: $0
Jul 08, 2024 Buy	Stock Option (Right to Buy) A-Award	Vider Itzhak Director	Director	6 250 Value: $4K
Jun 27, 2024 Buy	Stock Option (Right to Buy) A-Award	Goodman Mark Director	Director	6 250 Value: $4K
Jun 27, 2024 Buy	Common Stock J-Other	Goodman Mark	Director	0 Value: $0
Jun 27, 2024 Buy	Common Stock J-Other	Goodman Mark	Director	0 Value: $0
Jun 27, 2024 Buy	Stock Option (Right to Buy) A-Award	Goodman Mark Director	Director	6 250 Value: $4K
Jun 27, 2024 Buy	Stock Option (Right to Buy) A-Award	Miller Victor Chief Financial Officer	C-Suite Officer	200 000 Value: $126.0K
Jun 27, 2024 Buy	Stock Option (Right to Buy) A-Award	Miller Victor Chief Financial Officer	C-Suite Officer	200 000 Value: $126.0K
Jun 24, 2024 Buy	Common Stock P-Purchase	Safier Jacob 10 Percent Owner	10% Owner	10 000 Value: $6K
Jun 24, 2024 Sell	Common Stock S-Sale	Safier Jacob 10 Percent Owner	10% Owner	10 000 Value: $6K
Jun 24, 2024 Sell	Common Stock S-Sale	Safier Jacob 10 Percent Owner	10% Owner	10 000 Value: $6K
Jun 24, 2024 Buy	Common Stock P-Purchase	Safier Jacob 10 Percent Owner	10% Owner	10 000 Value: $6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORGENESIS INC.

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing ...

Read Full Profile Here